Dianna Quan

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction

J Glaser, K LaVigne, Dianna Quan et al. · Blood · 1989 · 139 citations · Full text

Screening for critical illness polyneuromyopathy with single nerve conduction studies

Marc Moss, Michele Yang, Madison Macht et al. · Intensive Care Medicine · 2014 · 72 citations

Neurological Disorder, Differential Diagnosis, Diagnosis +7

Impact of rituximab‐associated B‐cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients

Marilyn E. Levi, Dianna Quan, Joseph Ho et al. · Clinical Transplantation · 2009 · 68 citations · Full text

Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis

Angelo Giuseppe Caponetti, Claudio Rapezzi, Christian Gagliardi et al. · JACC Heart Failure · 2021 · 67 citations · Full text